MSL
IOVA icon

Mackay Shields LLC’s Iovance Biotherapeutics IOVA Stock Holding History

Mackay Shields LLC’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-24,000
Closed -$659K – 1487
2020
Q2 		$659K Sell
24,000
-49,138
-67% -$1.62M 0.01% 1135
2020
Q1 		$2.19M Sell
73,138
-5,300
-7% -$140K 0.02% 631
2019
Q4 		$2.17M Sell
78,438
-4,800
-6% -$109K 0.02% 843
2019
Q3 		$1.51M Sell
83,238
-3,200
-4% -$70.8K 0.01% 1015
2019
Q2 		$2.12M Buy
86,438
+43,820
+103% +$660K 0.01% 876
2019
Q1 		$405K Buy
42,618
+9,100
+27% +$88.4K ﹤0.01% 1224
2018
Q4 		$297K Sell
33,518
-982
-3% -$9.47K ﹤0.01% 1249
2018
Q3 		$388K Buy
+34,500
New +$490K ﹤0.01% 1033

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return